ABBV

merck-in-talks-to-acquire-revolution-medicines-for-about-$30b-–-wsj

ABBV Biotechnology MRK RVMD Uncategorized

Merck in talks to acquire Revolution Medicines for about $30B – WSJ

Jan 9, 2026

On the Move M&A Comments (18) Marko Georgiev/Getty Images News Merck (MRK) is in talks...

ABBV Biotechnology MRK RVMD Uncategorized

Revolution Medicines soars on report Merck in talks to buy (update)

Jan 8, 2026

ABBV Biotechnology Uncategorized

AbbVie sees negative Q4 EPS impact from IPR&D expenses

Jan 8, 2026

ABBV Biotechnology MRK Uncategorized

Merck rises as Wolfe upgrades to Outperform; AbbVie downgraded

Jan 8, 2026

ABBV Biotechnology Uncategorized

AbbVie flags $1.3B IPR&D charge, warns of Q4 earnings pressure

Jan 8, 2026

ABBV Biotechnology RVMD Uncategorized

AbbVie says not in talks to buy Revolution Medicines

Jan 7, 2026

ABBV Biotechnology ERAS RVMD Uncategorized

Revolution Medicines jumps on report AbbVie nears takeover

Jan 7, 2026

ABBV Biotechnology IRWD Uncategorized

Ironwood hits 52-week high as AbbVie-partnered Linzess boosts 2026 outlook

Jan 2, 2026

ABBV Biotechnology GMAB LYEL Uncategorized

Lyell Immunopharma pops on recent ASH data, immunotherapy expansion

Dec 22, 2025

abbvie,-bristol-myers,-merck-among-latest-to-announce-us.-drug-pricing-deals:-reuters

ABBV AZN Biotechnology BMY GILD LLY MRK NVO NVS PFE RHHBY Uncategorized

AbbVie, Bristol Myers, Merck among latest to announce U.S. drug pricing deals: Reuters

Dec 19, 2025

Comments (11) LIgorko/iStock via Getty Images Leading drugmakers, including AbbVie (ABBV), Bristol Myers Squibb (BMY),...

Next Page »